What are you looking for?
SoftOx SolutionsSoftOx Solutions

New ways of eradicating infections and fighting antimicrobial resistance. Patented and clinically proven.

  • Home
  • Technology
    • Our Focus
      • Antimicrobial Resistance
      • Biofilm
      • Chronic Wounds
      • Virus
      • Compromised Skin Conditions
    • Our Solutions
    • Scientific Publications
    • References
    • FAQ’s
  • Products
    • Disinfection
      • Buy Our Disinfection Products
    • Wound Care Human
    • Wound Care Animal
    • Respiratory care
  • Investors
    • Company Info
    • Investor Presentations
    • Stock Market Announcements
    • Financial Calendar & Reports
      • Largest Shareholders
    • Governance
    • Investor Relations Contacts
  • News
    • Stock Market Announcements
    • Media
    • Scientific Publications
    • Image Bank & Brand Guidelines
  • Our Team
    • Board of Directors
    • Management Team
    • Team Members
  • Contact Us

Author Archives: WebDevFirst

HomeSoftOx Solutions –  Articles by: WebDevFirst

Kan et norsk patent beskytte Forsvaret mot pandemier og biologiske stridsmidler?

Author WebDevFirst Posted on April 29, 2021March 7, 2022

FFI og oppstartsbedriften SoftOx Solutions skal eksperimentere med et norskutviklet produkt for desinfisering og sårskyll til bruk i Forsvaret.

Read More

Skal utvikle behandlinger mot biologisk krigføring

Author WebDevFirst Posted on April 29, 2021July 1, 2022
SoftOx og Forsvarets Forskningsinstitutt har gått sammen for å utvikle behandlinger mot virus som stridsvåpen. NATO og allierte styrker globalt kan bli et marked.

Read More

Startup awarded “corona contract”

Author WebDevFirst Posted on January 5, 2021July 1, 2022
Ose Water established itself in the north of Bygland to supply spring water to the international market. Towards the end of the corona year, they have a new and important source of income.

Read More

NorgesGruppen will sell SoftOx product

Author WebDevFirst Posted on January 5, 2021July 1, 2022
SoftOx Solutions’ distributor, Bonaventura Scandza, has signed an agreement with NorgesGruppen for the sale of SafeDеs alcohol-free hand disinfectant, as is stated in a stock exchange announcement.

Read More

Groundbreaking Danish inhalation treatment for Covid-19 passes tests in animals

Author WebDevFirst Posted on January 5, 2021September 9, 2022
A new treatment for COVID-19, developed by Danish researchers, has just passed a test in animals. The treatment is based on inhalation of particles that kill viruses and bacteria. The researchers behind it hope to be able to start the first safety tests in humans this spring.

Read More
1 2 3 4 Next page

Categories

  • Danish Media (3)
  • International Media (2)
  • Norwegian Media (26)
  • SoftOx Articles (1)

Recent Posts

  • August 30, 2022The European Defence Fund grant – the project and future opportunities
  • August 17, 2022Alkoholfri desinfisering ga de ansatte bedre inneluft og arbeidsmiljø
  • June 20, 2022Se til Hemsedal
  • June 20, 2022Tester ut alkoholfri desinfisering for Forsvaret

Tags

Air quality antimicrobial resistance Disinfection Inhalation Solution resistant bacteria SoftOx SoftOx Defense Solutions Wound Care

Address

Martin Linges vei 25, 1364, Fornebu, Norway

Call Us On

Front Desk: (+47) 948-59-599

Email Us

General inquiries: post@soft-ox.com

Investor relations: ir@soft-ox.com

Orders: order@soft-ox.com

SoftOx Solutions AS is a medtech and clinical-stage pharmaceutical company, founded in 2012. After years of research and product development with leading Nordic research institutions, SoftOx has developed a non-toxic and highly efficient antiseptic technology, which eradicates and prevents biofilm infections and is fully virucidal.

Recent Posts

  • August 30, 2022The European Defence Fund grant – the project and future opportunities
  • August 17, 2022Alkoholfri desinfisering ga de ansatte bedre inneluft og arbeidsmiljø
  • June 20, 2022Se til Hemsedal
Copyright © 2021 SoftOx Solutions. All rights reserved.
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Cookie settingsACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT